scholarly journals Value for Money in Social Care: The Role of Economic Evidence in the Guideline Development Process of the National Institute for Health and Care Excellence in England

2021 ◽  
pp. 303-317
Author(s):  
Annette Bauer ◽  
Michela Tinelli ◽  
Helen Weatherly ◽  
Beth Anderson ◽  
Bernadette Li ◽  
...  
Keyword(s):  
Development Process ◽  
Social Care ◽  
Guideline Development ◽  
Economic Evidence ◽  
Value For Money ◽  
Guideline Development Process

Role of Consumers in Guideline Development Process

2018 ◽  
Vol 159 (2) ◽  
pp. 211-212 ◽  
Author(s):  
Samantha Anne ◽  
Richard Rosenfeld
Keyword(s):  
Development Process ◽  
Positive Impact ◽  
Guideline Development ◽  
Neck Surgery ◽  
Patient Centered ◽  
Training And Education ◽  
Guideline Development Process ◽  
Risks And Benefits ◽  
Guidelines Development

Clinical practice guidelines (CPGs) inform patient care by providing recommendations based on a thorough examination of risks and benefits of medical care or intervention. With the ever-increasing importance placed on shared decision making, and because of the valuable perspective on patient-related topics and patient-centered outcomes, consumers of health care have been incorporated in the American Academy of Otolaryngology—Head and Neck Surgery Foundation CPG development process. Consumers bring a unique perspective and add transparency to the guideline development process. In addition, they are instrumental in formulating patient-friendly recommendations that are easier to understand. Studies that have been done to evaluate the role of consumers in the CPG development process found that consumers had a positive impact. In addition, studies report that consumers felt adequately prepared after appropriate training and education on the process. Further studies are needed to understand how to best engage, train, and educate consumers in future guidelines development.

Targeting Lyme

2014 ◽  
Vol 19 (4) ◽  
pp. 360-365 ◽  
Author(s):  
David Birnbaum
Keyword(s):  
Lyme Disease ◽  
Development Process ◽  
Conflicts Of Interest ◽  
Guideline Development ◽  
Medical Community ◽  
Diagnostic Tools ◽  
Content Type ◽  
Guideline Development Process ◽  
Vested Interests ◽  
The Usa

Purpose – The purpose of this paper is to describe recent passage of a private member's bill that can put Canada on a different path from the USA in attempting to resolve conflict that arose over how an influential clinical practice guideline for Lyme disease was developed. Design/methodology/approach – Narrative review. Findings – Critical appraisal of pertinent scientific literature is fundamental to the production of evidence-based practice guidelines. Perception of fairness and transparency in a guideline development process is fundamental to wide acceptance. Allegations of conflicts of interest and excluding opposing views in development of Lyme disease guidelines led to legislative interventions after insurers started basing denial of claims and licensing boards started responding to complaints against physicians whose treatment regimens were inconsistent with guideline statements on chronic Lyme disease. Opposing sides are both faced with limitations in available research evidence. Claims and counterclaims about availability of impartial subject matter experts free of vested interests arose; however, this has been compounded by failures in communication channels. Perhaps most importantly, and the focus of this viewpoint, wide perception among those afflicted of a flawed guideline development process makes it unlikely that all sides can reach agreement on this path. Canada, unlike the USA, is taking steps to include all stakeholders (including representatives of the medical community and of patients’ groups) in a review meeting to develop a comprehensive national framework. Research limitations/implications – This situation provides a noteworthy example of defining best practice in the difficult situations where stakes are high, diagnostic tools are flawed, some of those identified as experts have vested interests, and patients with unmet needs feel excluded. Originality/value – The next steps in Canada bear watching, both in terms of potentially resolving key conflicts around the one guideline document in question, and also as a potential model for a more successful guideline development process.

scholarly journals ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Guideline development process for the updated guidelines

2018 ◽  
Vol 37 (6) ◽  
pp. 2306-2308 ◽  
Author(s):  
W. Mihatsch ◽  
R. Shamir ◽  
J.B. van Goudoever ◽  
M. Fewtrell ◽  
A. Lapillonne ◽  
...  
Keyword(s):  
Parenteral Nutrition ◽  
Development Process ◽  
Guideline Development ◽  
Guideline Development Process

Guideline development process checklist

2016 ◽  
Vol 146 (6) ◽  
pp. 273-277
Author(s):  
Itziar Etxeandia-Ikobaltzeta ◽  
Romina Brignardello-Petersen ◽  
Alonso Carrasco-Labra ◽  
Pablo Alonso-Coello
Keyword(s):  
Development Process ◽  
Guideline Development ◽  
Guideline Development Process

scholarly journals Guidelines and Safety Practices for Improving Patient Safety

2020 ◽  
pp. 3-18
Author(s):  
Walter Ricciardi ◽  
Fidelia Cascini
Keyword(s):  
Patient Safety ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Development Process ◽  
Guideline Development ◽  
Improve Patient Safety ◽  
Safety Practices ◽  
Guideline Development Process ◽  
Improve Patient

AbstractThis chapter explains why clinical practice guidelines are needed to improve patient safety and how further research into safety practices can successfully influence the guideline development process. There is a description of the structured process by which guidelines that aim to increase the likelihood of a higher score are created. Proposals are made relating to (a) the live updating of individual guideline recommendations and (b) tackling challenges related to the improvement of guidelines.

Sign in / Sign up

Export Citation Format

Share Document